# CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin

> **NCT00969033** · PHASE2 · TERMINATED · sponsor: **Daiichi Sankyo** · enrollment: 8 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** CS-1008
- **DRUG:** irinotecan

## Key facts

- **NCT ID:** NCT00969033
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969033, "CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00969033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*